WebApr 13, 2024 · Furthermore, O 12 [email protected] was successfully applied to inhibit tumor growth, and more specific T-cell infiltration was observed in spleen and tumors of mice after treatment in the E.G7-OVA tumor model. Besides, O 12 [email protected] also achieved a good therapeutic effect in tumor recurrence inhibition and tumor prophylactic ... WebOct 22, 2024 · The growth of the tumors in the rBV group was inhibited compared with that observed in the PBS control group (no tumors developed), whereas the tumor growth in …
Spleen-Targeted mRNA Delivery by Amphiphilic Carbon Dots for Tumor ...
WebJul 31, 2024 · A therapeutic mouse tumour model was established by s.c. injecting E.G7-OVA cancer cells into the right flank region of the mice (C57BL/6), followed by the s.c. injection of cancer vaccines into ... WebOVA antigen-complexed CHP nanogel vaccine delivery system in a mouse E.G7-OVA tumor model. Mice were subcutaneously inoculated with E.G7-OVA tumor cells on one side of the back, and subcutaneously injected with OVA or the OVA/CHP nanogel vaccine on the other side of the back. Anti-PD-1 antibody was administered at defined intervals. neethone dance lyrics
A Potential Protein Adjuvant Derived from - PLOS
WebMay 29, 2024 · After tumor implantation, the mice were immunized (PBS, non-DC, OVAs-DC, or ALP/OVAs-DC). Interestingly, the ALP/OVAs-DC groups significantly showed retardation of E.G7 tumor growth compared to the OVAs-DC groups (Figure 5C). These results indicated that ALP-treated DCs had anti-tumor activity on the basis of the … WebDec 1, 2024 · Following the classical “priming + boosting” vaccination strategy for cancer immunotherapy (Fig. 1 a), we first examined the influence of vaccination route … WebJun 7, 2024 · E.G7-OVA tumor model was established by subcutaneously injecting 8 × 10 5 E.G7-OVA cells into the back skin of mice. And for bilateral tumor, 5 × 10 5 E.G7-OVA cells were injected on both sides of the back, respectively. 10 T cell enrichment in vivo. DiR-labeled DBMN-T was intravenously injected into mice with bilateral tumor. it has not erupted for at least ten years